Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-015588
Filing Date
2025-06-04
Accepted
2025-06-04 16:20:13
Documents
1
Period of Report
2025-06-03

Document Format Files

Seq Description Document Type Size
1 form4-06042025_040607.html 4  
1 form4-06042025_040607.xml 4 4168
  Complete submission text file 0001415889-25-015588.txt   5845
Mailing Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709
Business Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709 (919) 636-4530
FENNEC PHARMACEUTICALS INC. (Issuer) CIK: 0001211583 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address VIALE STEFINI 14 MILANO L6 00000
Business Address
Brughera Marco Maria (Reporting) CIK: 0001589776 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-32295 | Film No.: 251023352